Ovid Therapeutics

OVIDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$490.863 M

$2.63 -0.76%

Close of 7 Aug 2026

Revenue

$7.25M

#3235 by revenue

Earnings

-$17.4M

Loss-making

Shares outstanding

131,874,634

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#210EvolusEOLS$501.3M
#211Aquestive TherapeuticsAQST$494.3M
#212Ovid TherapeuticsOVID$490.9M
#213Benitec BiopharmaBNTC$468.2M
#214Q32 BioQTTB$464.4M

Where these numbers come from

Share counts and financials for Ovid Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.